Ruike; Yoshinao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ruike; Yoshinao.The latest application filed is for "anti-myostatin antibodies and methods of use".

Company Profile

9.7.18

Ruike; Yoshinao - Singapore SG
RUIKE; Yoshinao - Kanagawa JP
Ruike; Yoshinao - Shizuoka JP
RUIKE; Yoshinao - Synapse SG

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use Grant 11,454,633 - Ruike , et al. September 27, 2	2022-09-27
Anti-myostatin Antibodies And Methods Of Use App 20220275076 - RUIKE; Yoshinao ; et al.	2022-09-01
Anti-myostatin antibodies and methods of use Grant 11,359,009 - Ruike , et al. June 14, 2	2022-06-14
Anti-masp-1 Antibodies And Methods Of Use App 20210115154 - RUIKE; Yoshinao ; et al.	2021-04-22
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use App 20200317768 - RUIKE; Yoshinao ; et al.	2020-10-08
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use Grant 10,738,111 - Ruike , et al. A	2020-08-11
Cytotoxicity-inducing Therapeutic Agent App 20200123256 - Hoshino; Mayumi ; et al.	2020-04-23
Anti-c5 Antibodies And Methods Of Use App 20200031913 - RUIKE; Yoshinao ; et al.	2020-01-30
Nucleic acids encoding anti-C5 antibodies Grant 10,385,122 - Ruike , et al. A	2019-08-20
Antigen-binding Molecule Promoting Disappearance Of Antigens Having Plurality Of Biological Activities App 20190185557 - Igawa; Tomoyuki ; et al.	2019-06-20
Anti-c5 Antibodies And Methods Of Use App 20190062413 - RUIKE; Yoshinao ; et al.	2019-02-28
Anti-myostatin Antibodies And Methods Of Use App 20190002548 - RUIKE; Yoshinao ; et al.	2019-01-03
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use App 20180319877 - RUIKE; Yoshinao ; et al.	2018-11-08
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use App 20180319876 - RUIKE; Yoshinao ; et al.	2018-11-08
Antigen-binding Molecule Capable Of Binding To Plurality Of Antigen Molecules Repeatedly App 20180258161 - Igawa; Tomoyuki ; et al.	2018-09-13
Methods of neutralizing C5 with anti-C5 antibodies Grant 10,023,630 - Ruike , et al. July 17, 2	2018-07-17
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use Grant 10,000,560 - Ruike , et al. June 19, 2	2018-06-19
Anti-c5 Antibodies And Methods Of Use App 20180002415 - RUIKE; Yoshinao ; et al.	2018-01-04
Anti-C5 antibodies Grant 9,765,135 - Ruike , et al. September 19, 2	2017-09-19
Antigen-binding Molecule Promoting Disappearance Of Antigens Having Plurality Of Biological Activities App 20170022270 - Igawa; Tomoyuki ; et al.	2017-01-26
Anti-Myostatin Antibodies, Polypeptides Containing Variant Fc Regions, and Methods of Use App 20160200807 - RUIKE; Yoshinao ; et al.	2016-07-14
Anti-C5 Antibodies and Methods of Use App 20160176954 - RUIKE; Yoshinao ; et al.	2016-06-23
Antigen-binding Molecule Promoting Disappearance Of Antigens Having Plurality Of Biological Activities App 20150050269 - Igawa; Tomoyuki ; et al.	2015-02-19
Antigen-binding Molecule Capable Of Binding To Plurality Of Antigen Molecules Repeatedly App 20140234340 - Igawa; Tomoyuki ; et al.	2014-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.